Key Highlights
- Shares of Rocket Lab advanced 11.3%, reaching an intraday peak of $123.94 following Needham’s decision to elevate its price target from $95 to $120 while maintaining a Buy recommendation.
- Cantor Fitzgerald increased its target to $96 from $85, highlighting improved launch performance and an expanding space systems business.
- First-quarter revenue totaled $200.35 million, representing a 63.4% year-over-year increase and surpassing the consensus forecast of $189.65 million.
- Earnings per share matched projections at -$0.07, with management boosting its second-quarter outlook.
- The stock carries a consensus rating of “Moderate Buy” with an average analyst target of $91.79.
Shares of Rocket Lab USA (RKLB) climbed 11.3% during Monday’s trading session after Needham & Company increased its price objective on the aerospace company from $95 to $120, reaffirming its Buy recommendation.
The stock touched an intraday peak of $123.94 before closing near $117.35. Trading volume surged to approximately 53 million shares, significantly exceeding the typical daily average of 23.3 million.
The rally followed an impressive first-quarter earnings release. Rocket Lab delivered revenue of $200.35 million for the period, topping analyst projections of $189.65 million and marking a robust 63.4% year-over-year expansion.
The company reported earnings per share of -$0.07, matching Street expectations. This marked an improvement from the -$0.12 per share loss recorded in the same quarter last year, demonstrating progress in narrowing losses.
Management also upgraded its second-quarter guidance, further bolstering investor confidence in the company’s trajectory.
Wall Street Analysts Express Confidence
Cantor Fitzgerald added to the optimistic sentiment, elevating its price target to $96 from $85 while maintaining an Overweight rating. The firm highlighted Rocket Lab’s execution capabilities and its broad service portfolio, spanning the Electron launch vehicle, the Haste hypersonic testing platform, and the forthcoming Neutron rocket program.
Stifel Nicolaus reaffirmed its Buy stance and raised its target to $105 from $90. Bank of America maintains a $120 price objective. Citigroup restated an Outperform rating late last week.
Despite these bullish projections from individual firms, the average consensus target stands at $91.79, notably below the current trading level. This disconnect illustrates the rapid pace of the stock’s recent appreciation.
Among analysts following RKLB, two rate it as a Strong Buy, ten recommend Buy, four maintain Hold ratings, and one has issued a Sell recommendation.
First-Quarter Performance Breakdown
Rocket Lab posted a negative return on equity of 11.72% and a net margin of -26.87%, typical metrics for a growth-phase aerospace enterprise.
The first-quarter outperformance stemmed from robust results across both launch operations and spacecraft systems divisions. Cantor emphasized the company’s dual launch facility infrastructure in New Zealand and the United States as a competitive differentiator.
The company commands a market capitalization of approximately $66.82 billion, maintains a minimal debt-to-equity ratio of 0.02, and boasts a current ratio of 4.47, indicating strong short-term financial flexibility.
Technical indicators show the 50-day moving average at $72.88 and the 200-day moving average at $68.50, both considerably below present trading levels.
Insider activity has leaned toward selling recently. Over the past three months, company insiders disposed of approximately 233,449 shares valued at more than $16.4 million. SVP Arjun Kampani executed sales in early March at an average price of $69.59, while Director Merline Saintil sold at $75.04. Insiders control roughly 8.4% of outstanding shares, with institutional investors accounting for 71.78%.
Analyst consensus projects full-year earnings per share of -$0.22 for the current fiscal period.
